These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 16397221)

  • 1. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
    Hruban RH; Adsay NV; Albores-Saavedra J; Anver MR; Biankin AV; Boivin GP; Furth EE; Furukawa T; Klein A; Klimstra DS; Kloppel G; Lauwers GY; Longnecker DS; Luttges J; Maitra A; Offerhaus GJ; Pérez-Gallego L; Redston M; Tuveson DA
    Cancer Res; 2006 Jan; 66(1):95-106. PubMed ID: 16397221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of mouse mammary tumour models for human breast cancer: comparative pathology.
    Cardiff RD
    Microsc Res Tech; 2001 Jan; 52(2):224-30. PubMed ID: 11169869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum.
    Weiss WA; Israel M; Cobbs C; Holland E; James CD; Louis DN; Marks C; McClatchey AI; Roberts T; Van Dyke T; Wetmore C; Chiu IM; Giovannini M; Guha A; Higgins RJ; Marino S; Radovanovic I; Reilly K; Aldape K
    Oncogene; 2002 Oct; 21(49):7453-63. PubMed ID: 12386807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of Exocrine Pancreatic Neoplasms in Transgenic Mice.
    Longnecker DS
    Comp Med; 2004 Feb; 54(1):18-21. PubMed ID: 15382335
    [No Abstract]   [Full Text] [Related]  

  • 5. The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
    Bardeesy N; Sharpless NE; DePinho RA; Merlino G
    Semin Cancer Biol; 2001 Jun; 11(3):201-18. PubMed ID: 11407945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma of the exocrine pancreas: the histology report.
    Capella C; Albarello L; Capelli P; Sessa F; Zamboni G; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S282-92. PubMed ID: 21459334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical development of genetically engineered animals as human disease models.
    Nomura T
    Lab Anim Sci; 1997 Apr; 47(2):113-7. PubMed ID: 9150486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer.
    Clark CE; Beatty GL; Vonderheide RH
    Cancer Lett; 2009 Jun; 279(1):1-7. PubMed ID: 19013709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Models of pancreatic cancer.
    Hall PA; Lemoine NR
    Cancer Surv; 1993; 16():135-55. PubMed ID: 8348533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Kras-mediated pancreatic tumorigenesis in zebrafish.
    Davison JM; Woo Park S; Rhee JM; Leach SD
    Methods Enzymol; 2008; 438():391-417. PubMed ID: 18413263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.
    Shappell SB; Thomas GV; Roberts RL; Herbert R; Ittmann MM; Rubin MA; Humphrey PA; Sundberg JP; Rozengurt N; Barrios R; Ward JM; Cardiff RD
    Cancer Res; 2004 Mar; 64(6):2270-305. PubMed ID: 15026373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude mice.
    Tsuji K; Yang M; Jiang P; Maitra A; Kaushal S; Yamauchi K; Katz MH; Moossa AR; Hoffman RM; Bouvet M
    JOP; 2006 Mar; 7(2):193-9. PubMed ID: 16525203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.
    Saloman JL; Albers KM; Cruz-Monserrate Z; Davis BM; Edderkaoui M; Eibl G; Epouhe AY; Gedeon JY; Gorelick FS; Grippo PJ; Groblewski GE; Husain SZ; Lai KKY; Pandol SJ; Uc A; Wen L; Whitcomb DC
    Pancreas; 2019 Jul; 48(6):759-779. PubMed ID: 31206467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer.
    Hanahan D; Wagner EF; Palmiter RD
    Genes Dev; 2007 Sep; 21(18):2258-70. PubMed ID: 17875663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse nomenclature and maintenance of genetically engineered mice.
    Linder CC
    Comp Med; 2003 Apr; 53(2):119-25. PubMed ID: 12784845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer in mice and man: the Penn Workshop 2004.
    Hruban RH; Rustgi AK; Brentnall TA; Tempero MA; Wright CV; Tuveson DA
    Cancer Res; 2006 Jan; 66(1):14-7. PubMed ID: 16397208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mouse Tumor Biology Database: integrated access to mouse cancer biology data.
    Krupke D; Näf D; Vincent M; Allio T; Mikaelian I; Sundberg J; Bult C; Eppig J
    Exp Lung Res; 2005 Mar; 31(2):259-70. PubMed ID: 15824024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic.
    Mossbrugger I; Hoelzlwimmer G; Calzada-Wack J; Quintanilla-Martinez L
    Verh Dtsch Ges Pathol; 2007; 91():98-103. PubMed ID: 18314602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application and recent advances of laboratory mouse in human cancer research].
    Liu EQ; Kitajima S; Morimoto M
    Ai Zheng; 2005 Feb; 24(2):249-54. PubMed ID: 15694046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular changes in pancreatic cancer.
    Buchholz M; Gress TM
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1487-97. PubMed ID: 19828010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.